<code id='F67A791174'></code><style id='F67A791174'></style>
    • <acronym id='F67A791174'></acronym>
      <center id='F67A791174'><center id='F67A791174'><tfoot id='F67A791174'></tfoot></center><abbr id='F67A791174'><dir id='F67A791174'><tfoot id='F67A791174'></tfoot><noframes id='F67A791174'>

    • <optgroup id='F67A791174'><strike id='F67A791174'><sup id='F67A791174'></sup></strike><code id='F67A791174'></code></optgroup>
        1. <b id='F67A791174'><label id='F67A791174'><select id='F67A791174'><dt id='F67A791174'><span id='F67A791174'></span></dt></select></label></b><u id='F67A791174'></u>
          <i id='F67A791174'><strike id='F67A791174'><tt id='F67A791174'><pre id='F67A791174'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:625
          An FDA sign — health policy coverage from STAT
          Sarah Silbiger/Getty Images

          WASHINGTON — There’s about to be a new acronym in town.

          The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

          advertisement

          That overhaul includes a new name: Meet the Office of Inspections and Investigations.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Listen: Biogen's messy board & Laronde's data problem
          Listen: Biogen's messy board & Laronde's data problem

          SammyKimballforSTATCanunicornssurvivewithoutdata?Didbiotechgetoveritsskis?AndwhatisgoingonatBiogen?W

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Immunocompromised patients offer clues on chronic Covid

          ThiscolorizedelectronmicroscopeimageshowsSARS-CoV-2,indicatedinyellow,emergingfromthesurfaceofcells,